Maybe so. But this is one trial. If they took on a partner 7 to 8 years ago where would we be. We wouldn’t be diluted beyond the imagination. Where would we be with Direct or other indications for “L”.
You do not know. I do not but think the assets would have been monetized faster. And with a proper partner we would not be attacked so easily. But everyone just wants to forgive and forget any promises made that never materialized. And according to the Uber Bulls if I complain then I must not understand biotech. It is really a bad argument.
I hope Bigger is sincere that he has ideas to get proper valuation because this team does not. I am not looking to sell. Haven’t been for ten years and looking for valuation with all solid tumors in the mix so I hope Bigger can help them out.